Fennec Pharmaceuticals Inc. (TSX:FRX)
15.04
-0.25 (-1.64%)
Sep 24, 2026, 3:56 PM EST
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 35 employees as of December 31, 2025. The number of employees increased by 3 or 9.38% compared to the previous year.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
2.40M CAD
Profits / Employee
-131.87K CAD
Market Cap
526.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | 3 | 9.38% |
| Dec 31, 2024 | 32 | 3 | 10.34% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | 26 | 260.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eupraxia Pharmaceuticals | 49 |
| Bright Minds Biosciences | 26 |
| Satellos Bioscience | 21 |
| BriaCell Therapeutics | 16 |
| Helix BioPharma | 7 |
Fennec Pharmaceuticals News
- 8 days ago - Fennec presents results from STS-J01 clinical trial evaluating Pedmark - TheFly
- 8 days ago - Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026 - GlobeNewsWire
- 10 days ago - Fennec Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - Fennec Pharmaceuticals Slides: Corporate presentation - Filings
- 5 weeks ago - Fennec price target raised to $16 from $13 at Wedbush - TheFly
- 5 weeks ago - Fennec price target raised to $18 from $16 at B. Riley - TheFly
- 6 weeks ago - Fennec Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Fennec Pharmaceuticals Earnings release: Q2 2026 - Filings